Template:New Product: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
:» For offers refer to: [mailto:[email protected] [email protected]] | :» For offers refer to: [mailto:[email protected] [email protected]] | ||
<br/> | |||
<br/> | |||
<br/> | |||
<br/> | |||
<br/> | <br/> | ||
<br/> | <br/> | ||
<br/> | <br/> | ||
</div> | </div> | ||
Revision as of 15:27, 11 July 2019
- The new MitoKit-CII
- The cell permeable compounds MitoKit-CII, including succinate-nv and malonate-nv, are the first generation of NeuroVive Pharmaceutical AB's prodrugs and have been developed to stimulate or inhibit Complex II of the respiratory electron transfer system in living cells. The MitoKit-CII will expand the toolbox for evaluating the role of mitochondria in disease.
- » For more information: wiki.oroboros.at/index.php/MitoKit-CII
- » For offers refer to: [email protected]
